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ABSTRACT
Objectives: To elicit the perceptions and preferences of
patients with rheumatoid arthritis regarding information
and participation in treatment decision-making. To analyse
the patients’ narratives on the background of the ethical
discourse on various approaches to treatment decision-
making.
Design: In-depth interviews with themes identified using
principles of grounded theory.
Participants: 22 patients with long-standing rheumatoid
arthritis.
Main outcome measures: Qualitative data on patients’
perceptions and preferences regarding information and
participation in decision-making about treatment.
Results: Decision-making about treatment has been
described by the patients as a process consisting of
different stages with shifting loci of control and
responsibility. Patients initially received one treatment
recommendation and were not aware of alternative
treatment options. Those participants in this study who
wanted information about negative effects of a treatment
cited ‘‘interest in one’s own health’’ and the potential ‘‘use
of information’’ as reasons for their preference. The
physicians’ expert knowledge and clinical experience
regarding the effects of medication were cited as
arguments by patients for a treatment recommendation.
Conclusions: The patients’ accounts of decision-making
about treatment differ from models of physician–patient
relationship that have been put forward in ethical
discourse. These differences may be relevant with respect
to the starting point of an ethical analysis of treatment
decision-making. Patients’ accounts with respect to a lack
of information on treatment alternatives point to ethically
relevant challenges regarding treatment decision-making
in clinical practice.
Information and patients’ right to self-determina-
tion have been central aspects of the ethicolegal
debate on decision-making in medicine during
recent decades. The emphasis on individual pre-
ferences and the demand for respect for the rights
of citizens—also regarding decisions about treat-
ment—has led to the ideal of informed decision-
making. Patients should be empowered by infor-
mation about their diagnosis, treatment options
and prognosis to make treatment decisions that
correspond to their preferences and values.1 2 This
approach to decision-making stands in contrast to
the traditional, paternalistic model of decision-
making, according to which physicians make
treatment decisions based on their knowledge
and views with respect to the best medical
treatment for a patient.
In the past two decades, the model of informed
decision-making has been increasingly criticised. It
has been argued that the model of the informed
decision reduces the role of physicians to techni-
cians who, according to this model, should use
their knowledge and skills to implement patients’
wishes. Thereby the values of the medical profes-
sion no longer form part of the treatment decision-
making process.3 4 Another line of argument uses
the results of empirical research according to which
the quantity and complexity of information may
overburden a significant proportion of patients.4 5
Various authors have proposed alternatives to
the models of paternalistic and informed decision-
making, taking into account the possible roles of
patient and physician and other criteria relevant to
distinguish the various approaches to medical
decision-making.3 4 6 7 Table 1 summarises the
characteristics of four often-cited models of the
physician–patient relationship as put forward by
Emanuel and Emanuel.3
Empirical studies on information and participa-
tion in decision-making about treatment so far
have focused on eliciting patients’ preferences by
means of quantitative methods.5 8 There is a
scarcity of qualitative studies that explore patients’
perceptions of decision-making and the underlying
reasons for their information and participation
preferences.4 9 Detailed descriptions of decision-
making in medicine can serve as a starting point for
ethical analysis. In addition, data about patients’
preferences and their reasons for them inform the
debate about ethical aspects of decision-making
about treatment from the perspective of a party
affected by the decision.
This qualitative study presents the findings of
semistructured interviews regarding the percep-
tions and preferences of 22 patients with long-
standing rheumatoid arthritis concerning treat-
ment decisions.
The aims were to elicit from patients with
rheumatoid arthritis:
c an account of the perceptions regarding deci-
sion-making about medication;
c their preferences regarding information in the
context of decision-making about medical
treatment, and the reasons for these prefer-
ences;
c their preferences with respect to participation
in the decision.
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Our results are discussed with reference to the various models
of physician–patient interaction that have been advanced in the
discussion about ethically acceptable approaches to treatment
decision-making as well as relevant empirical findings.
PARTICIPANTS AND METHODS
Participants and procedures
In accordance with the vote of the research ethics committee of
the Medical Faculty of the University Erlangen-Nuremberg
(Germany), patients were invited to participate in the study by
the physicians working in the outpatient clinic of the University
Hospital Erlangen. Inclusion criteria were a diagnosis of
rheumatoid arthritis according to the definition of the
American College of Rheumatology, a sequence of at least
two therapeutic regimens and the ability to speak German. In
accordance with the current guidelines for the management of
rheumatoid arthritis, patients at this stage may be treated with
any of a variety of substances.10
The sampling strategy consisted of recruitment of patients
who consecutively visited the outpatient clinic of the university
hospital and who had been considered as potential participants
by their physicians. In addition to this convenience sample, the
interviewer (JS) pointed out characteristics that should be
considered by the clinicians when approaching potential
participants for the study (theoretical sampling—for example,
maximum variation sampling). Written informed consent was
elicited by the interviewer. Semistructured interviews were
conducted on the basis of an interview guide (see appendix) and
audiotaped. Demographic data were collected by self report.
Interviews were scheduled in patients’ homes or in an office of
the university hospital, depending on the patients’ choice.
Data analysis
Interview transcripts were analysed according to principles of
grounded theory as described by Strauss and Corbin.11
Grounded theory consists in a set of analytical techniques that
were originally designed for the purpose of sociological enquiry.
Like other qualitative methods, it is used to explore data with a
critical awareness of assumptions and theoretical preconcep-
tions. The aims of this methodological approach may be
described as the generation of new concepts, hypotheses and,
if possible, new—empirically grounded—theories relevant to a
research topic, which emerge as a result of the iterative process
of data analysis and data interpretation.
In this study, essential principles of grounded theory—
namely the constant comparison of data, open coding, writing
memos and theoretical sampling—have been used to explore
patients’ perceptions and preferences regarding treatment
decision-making. After verbatim transcription of the audio-
taped interviews and a check of data, all transcripts were
analysed by the first author, sentence by sentence. Sections
(sentences or small paragraphs) of the first transcripts concern-
ing patients’ perceptions and preferences with respect to
treatment decision-making were selected and labeled with a
code (a word or phrase). The codes express the content of the
analysed data as understood and conceptualised by the
researcher in the light of the research focus (open coding).
After the iterative process of data gathering and data analysis
and the process of constant comparison of data, similar
concepts were merged into more abstract categories. To
illustrate the conceptualisation of data, quotes from the
interviews were selected and allocated to categories derived
from the data.
To gain a sample with a maximum variation of characteristics
that may be relevant to the research topic, the sampling of
participants was based on considerations of factors known to
influence the narratives of the patients (eg, education, gender,
age) (theoretical sampling).11 By writing memos, we were able
to be as transparent and reflective as possible regarding
decisions made during the process of data gathering and
interpretation. To reduce interpretative bias, we regularly
discussed among ourselves the transcripts of the interviews
and the drafts of the data analysis. In addition, transcripts and
preliminary interpretations were presented at interdisciplinary
meetings every 2 weeks between the first author and two other
researchers who were also conducting qualitative research
projects. The presentation of preliminary findings at several
interdisciplinary conferences and discussions about the inter-
pretation of data among the authors during the drafting of this
paper were additional occasions on which data analysis and
interpretation was critically reviewed. The enrolment of
participants was stopped once the analysis of the most recent




Twenty-two patients were invited to participate in the study,
all of whom agreed to take part and be interviewed. Their mean
age was 56.9 years (19 women and 3 men); all had public health
insurance. Further information about the sample of participants
is provided in table 2.
Perceptions of decision-making about medical treatment
The narratives of interviewees regarding their perceptions of
medical treatment decision could be interpreted as a four-stage
process (table 3). The initial stage has been descibed by
participants as brief discussions with their physicians about a
new treatment. Physicians recommended a specific treat-
ment and patients perceived the situation at this stage of the
Table 1 Key characteristics of medical decision-making models3
Variable
Model
Paternalistic Deliberative Interpretative Informed
Patient’s values Objective, shared by patient
and physician
Open to development and revision through
moral discussion
Inchoate and conflicting, requiring
elucidation
Defined, fixed and known to patient
Physician’s task Promoting patient’s well-
being as perceived by
physician
Persuading patient with respect to health-
related values as well as informing the
patient and implementing the patient’s
selected intervention
Elucidating and interpreting patient’s values
as well as informing the patient and
implementing the patient’s selected
intervention
Providing relevant factual
information and implementing the
patient’s selected treatment
Physician’s role Guardian Friend/teacher Advisor Competent technical expert
Flow of information Patient r physician Patient « physician Patient « physician Patient r physician
Locus of control Physician Patient Patient Patient
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decision-making process as one where there was no treatment
alternative. Interviewer: ‘‘When you were discussing a new
treatment, did the doctor ever ask you what was important to
you concerning the treatment …?’’ Patient: ‘‘No, he didn’t ask
me, but he said something about side effects and how long it
would take, and that we need to change something if things get
inconvenient […]. So I just said, well, then we must try it.
There are no alternatives, there was no alternative’’ (patient 9).
Three different types of response of the patients to a
treatment recommendation by the physician were identified:
c Consent: This type of response was characterised by
consent to the proposed medication without any further
discussion. As reasons for this type of reaction patients cited
a lack of medical knowledge and a hope that health would
improve after the recommended treatment: ‘‘I relied on the
physicians to give me the right recommendation […] he had
recommended this to me, told me that I should try it and so
I did’’ (patient 2).
c Discussion: This category was characterised by patients’
asking questions about positive and negative effects of the
proposed medication and about alternatives. ‘‘I always ask
for options, what [treatment] might be possible for me […];
that was the way I did it and that was the way the dialogue
with the doctor went’’ (patient 13).
c Veto: This type of response was characterised by rejection of
the recommended treatment. Patients feared negative
effects either because of earlier experiences with the
proposed medication or based on theoretical knowledge
about possible adverse effects. According to the patients, the
rejection of a recommended treatment led to another
treatment recommendation by the physician. ‘‘[...] and then
came Remicade [...] that would have been not bad but it
affects my vision and I hardly see anything with my right
eye so I did not want it [...] and then we started with Arava’’
(patient 5).
During a third stage of the decision-making process (‘‘testing
of medication’’; see table 3), patients gathered experiences with
the recommended medical treatment. As a consequence,
participants in this study reported situations in which they
had to stop the treatment because of unacceptable effects of the
medication: ‘‘And then I was feeling really bad, I simply
couldn’t tolerate it. I had nausea and although the doctor, I can
not remember her name, was very sorry I had to break it off’’
(patient 2).
The final stage of decision-making has been described as one
in which physicians and patients exchanged their evaluations of
the treatment decision: ‘‘When I had the feeling that I was not
well, then I said, tell me, is there something else? Or when I was
feeling well but the blood tests were bad, then the doctor said,
well, now we should add this and that. I think this was like a
partnership somehow‘‘ (patient 12).
Preferences regarding information and participation in medical
decision-making
In this study, all but two patients preferred to be informed
about possible negative effects. ‘‘Interest in one’s own health’’
and ‘‘use of information’’ were identified as two categories
summarising the rationale underlying the preference for
information about possible negative effects.
c Interest in one’s own health: The fact that it is the patients’
‘‘own health’’ that is affected by the treatment was cited as
one argument in favour of information about possible
negative effects: ‘‘Well, you know, it’s important for me to
know what kind of medication it is […], the side effects, you
know, what might happen. I’m curious and so I also read
about it, you know, it is about my health’’ (patient 10).
c Use of information: Patients argued that knowledge about
the potential risks of a medication enabled them to identify
negative effects as possible causes of the new treatment.
This again allowed them to react to any changes experi-
enced—for example, by modifying the dosage or by taking
additional medication in order to counteract the negative
effects: ‘‘All medication has side effects, and then you must
know how to protect yourself against it’’ (patient 9).
Two patients in this study were hardly or not at all interested
in information about possible negative effects of a recom-
mended treatment. These patients argued that first, such
knowledge might create anxiety concerning the realisation of
possible negative effects and that, second, medical treatment
was necessary to improve their state of health. Therefore,
information about potential risks would not have any
consequences: ‘‘I think you should at least be a little informed,
and obviously you know that any medication has negative
effects, but I don’t want to know about that in detail. If an
operation comes up, then he [the physician] says that he must
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alternative
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inform me that you might not wake up any more and what
might happen to you because of the anaesthesia, and I always
say I don’t want to know about that […]. I need to have it done
anyway.’’ Interviewer: ‘‘And why don’t you want to know it?’’
Patient: ‘‘I think this causes even more anxiety’’ (patient 5).
All patients favoured a treatment recommendation by their
physicians. The physician’s expert knowledge, clinical experi-
ence with the medication and perception of the state of health
of a patient were cited as arguments in favour of treat-
ment recommendations: ‘‘Yes, because I think if he recom-
mends it, then he has experience with it and then he can tell me
from his experience that it has helped a lot of other patients
and, well, how it will work with me, that I must try it myself’’
(patient 7).
DISCUSSION
Selection of participants and method
This qualitative study provides an account of the perceptions
and preferences of patients with rheumatoid arthritis regarding
decision-making about medical treatment. According to current
guidelines, patients with rheumatoid arthritis may be treated
with a variety of substances, including non-steroidal anti-
inflammatory drugs, corticosteroids, disease-modifying anti-
rheumatic drugs or biologic agents. The different treatment
approaches vary with respect to the approximate time to
benefit, dosage and mode of application (eg, oral, subcutaneous,
intravenous), potential negative effects and risks that need
regular monitoring, and costs.10 Against this clinical back-
ground, patients with rheumatoid arthritis provide a good
model for the investigatation of patients’ perceptions and
preferences in situations of decision-making in which there is
more than one choice of medical treatment.
Because our sample is not representative of the group of
patients with rheumatoid arthritis, the results cannot be
generalised to all patients with the disease. The patients were
invited by their physicians, so there may have been a selection
bias. Therefore, the views elicited in this study may not cover
the whole range of views of patients with rheumatoid arthritis.
In addition, selective memory, socially desirable answers and
the influence of positive or negative effects of the treat-
ment experienced are possible factors that may have influenced
the perceptions and preferences of patients stated in the
interviews.
One advantage of the qualitative approach and the rationale
for using it in this study is the possibility of gaining in-depth
information about patients’ perceptions of decision-making
regarding medical treatment.12 This approach allows an
empirically based reconstruction of the decision-making process
as perceived by the patients taking part. It thereby provides a
heuristic basis for the construction of research instruments in
future quantitative studies in which the perceptions and views
of patients with various illnesses regarding information and
participation in medical treatment may be investigated. A
second advantage is that the results of the interpretation of data
can be used for a comparative analysis between the empirically
based findings and theoretical models of treatment decision-
making put forward in the literature. Finally,the semistructured
approach allowed the researcher to elicit patients’ preferences
regarding information and participation in decision-making and
also to explore the underlying reasons. The research can thereby
inform the debate on ethical approaches to decision-making
using the perspective of one group of patients.
Perceptions of decision-making about medical treatment
The reconstruction of the narratives of patients emphasises a
procedural character of decision-making about treatment, as has
been pointed out in earlier sociological research.13 Decision-
making about treatment, as viewed by the patients, is not a
single event but is, rather, a sequence of decisions. Patients
initially respond to treatment suggestions by their physicians,
whereas in the later stages of the decision-making process they
make their own decisions—for example, modifying the dosage
or stopping the treatment or re-evaluating the treatment
together with their physician. The reconstructed model of
treatment decision-making provides a specific, detailed perspec-
tive on the interaction between patient and physician and
thereby furthers the understanding of the process. The detailed
accounts with respect to the various stages of the decision-
making are relevant for the ethical analysis in so far as it is the
basis for a concept of shifting loci of control during the process
of decision-making about treatment. According to this view of
decision-making, it is neither only the patient nor only the
physician who makes decisions; rather, both parties contribute
to the process at different stages with different intensities. This
view of the dynamics of the decision-making process is not well
reflected by models on decision-making—such as the models of
paternalistic or informative decision-making—according to
which, control for the decision rests either with the patient or
with the physician. While intermediate models, such as the
deliberative models, leave some room for dynamics with respect
to influence and control of decision-making on the part of
patients as well as physicians, the reconstructed model adds a
more detailed perspective with respect to different stages of the
decision-making process. In addition to their relevance as a
starting point for ethical analysis, patients’ perceptions of
treatment decision-making as a process also seem relevant to
ethically appropriate conduct in clinical practice. As pointed
out, the interviewees in this study perceived follow-up visits as
an important occasion on which to air their experiences with
the recommended treatment. At this stage, they perceived
decision-making more as a partnership, which differs from the
perceptions regarding the initial stage of decision-making and
which requires skills of physicians to adapt their approach to
decision-making.
Various views of decision-making contribute to the debate on
ethical aspects of the patient–physician relationship, in the
sense that different descriptions of the decision-making may
change the starting point for the ethical analysis. The account
of decision-making put forward in this paper is based on the
narratives of one patient group, and interviews with other
groups of patients or physicians might offer different perspec-
tives on decision-making about medical treatment.
Participants in our study reported that they had received little
information about various treatment options when discussing
new medication with their physicians. Instead, physicians
routinely informed their patients only about the treatment
they would recommend. This finding agrees with results from
other interview studies and from observational studies.14 15 The
preselection of treatment options without naming alternatives
seems problematic for at least two reasons: first, patients are
restricted in exercising their right to self-determination if they
are not informed about the spectrum of existing treat-
ment options. Second, this preselection may also violate the
principles of beneficence and non-maleficence, because different
treatment options may further the well-being of patients more
or less, depending on the patients’ individual values and
preferences.16
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Preferences regarding information and participation in decision-
making about treatment
All but two patients wished to be informed about potential
adverse effects of a treatment. ‘‘Interest in one’s own health’’
and the possible ‘‘use of information’’ were identified as factors
generating patients’ demand for information. In the literature,
information has been often discussed as a prerequisite to
exercising the right to self-determination and to making an
autonomous decision.4 17 The analysis of the interviews suggests
that other reasons than the use of information to make an
autonomous decision play an important role in patients’
preferences for information. This finding of the study may
provide an explanation for the divergent results of quantitative
studies, which indicate that patients want to be informed, but
that only to a lesser degree do they wish to share responsibility
in healthcare decisions.5
All the patients interviewed in this study wanted a treatment
recommendation by their physician, giving as their reason a self-
perceived lack of theoretical and practical expertise concerning
the available treatment options. In this respect, the preferences
expressed by the interviewees fit with an understanding of the
role of the physician as ‘‘friend’’ or ‘‘teacher’’, as has been
suggested in the model of deliberative decision-making.3 This
concept of the patient–physician relationship does take into
account that decision-making between the two parties may
appropriately involve value judgments on the part of the
physician—for example, with respect to the risks and benefits of
a treatment option. While recommendation of a treatment has
been criticised as unduly influencing patients, we would argue
in favour of it. First, it is questionable whether it is theoretically
even possible to make a strict fact value distinction, much less
to implement such an approach as part of the communication
process between patients and physicians.18 Second, data from
representative quantitative studies show that most patients
want such recommendations, and in this sense to give such
guidance is to respect patients’ expressed wishes.5 Finally, it
could be argued that an autonomous decision is not one that is
based on descriptive information only, but is one that has been
made also in the light of interpretation and value judgements of
other persons. A prequisite for such an ideal of decision-making
is, of course, that physicians provide detailed information
including treatment alternatives and also are reflective and
transparent with respect to their value judgements.
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APPENDIX
Interview guide (translated version)
I Perception of treatment decision-making
Question 1 Mr/Mrs ... , first of all I would be interested to hear about what happened
after you had heard about the fact that you have rheumatoid arthritis?
Clarify
c What kind of information about suggested treatment was received?
c What kind of information did your physicians want in the context of treatment
decision-making?
c Any preferences on the part of your physician with respect to treatment?
c Any treatment alternatives suggested?
c Who took part in discussions about treatment?
c Any discussions about treatment with persons other than your physician (friends,
family, other patients, etc)?
c Any information resources about illness and treatment options (eg internet,
television)?
II Preferences regarding information and participation in
decision-making
Question 2 What was important to you when discussing a new treatment for your
illness?
Clarify
c Satisfied with level of information/participation?
c Wish to be informed about treatment? Why (not)?
c Interest in specific information about treatment? Why?
c Wish to get treatment recommendation? Why (not)?
III Demographic data
Age, gender, education, insurance, beginning of illness, nationality.
Clinical ethics
J Med Ethics 2008;34:775–779. doi:10.1136/jme.2007.023705 779
 group.bmj.com on July 8, 2013 - Published by jme.bmj.comDownloaded from 
doi: 10.1136/jme.2007.023705
 2008 34: 775-779J Med Ethics
 
J Schildmann, M Grunke, J R Kalden, et al.
 
arthritis
preferences of patients with rheumatoid 
qualitative study of the perceptions and
decision-making about treatment: a 
Information and participation in
 http://jme.bmj.com/content/34/11/775.full.html




Article cited in: 
 
 http://jme.bmj.com/content/34/11/775.full.html#ref-list-1
This article cites 15 articles, 1 of which can be accessed free at:
service
Email alerting
the box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in
Collections
Topic
 (417 articles)Research and publication ethics   
 
Articles on similar topics can be found in the following collections
Notes
 http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
 http://journals.bmj.com/cgi/reprintform
To order reprints go to:
 http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
 group.bmj.com on July 8, 2013 - Published by jme.bmj.comDownloaded from 
